Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial

Singapore National Medical Research Council; UK Department of Health and Social Care; UK Foreign, Commonwealth, and Development Office; UK Medical Research Council; Wellcome Trust; and UK Research and Innovation Medical Research Council.

Authors

Institutions

Publication Details

Journal
The Lancet Infectious Diseases
Published
2025-05-22
DOI
https://doi.org/10.1016/s1473-3099(25)00151-3
Citations
6
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
8.38

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial

Rholine S. Veto, Erlina Burhan, Angela M. Crook, Anchalee Avihingsanon et al.
6 citations
The Lancet Infectious Diseases
Tuberculosis Research and Epidemiology
8.38
article

Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial

Rholine S. Veto, Erlina Burhan, Angela M. Crook, Anchalee Avihingsanon, C S G Cousins, Christine Sekaggya‐Wiltshire, Jani J.R. Sugiri, Victoria B. Dalay, Irawaty Djaharuddin, Tutik Kusmiati, Nicholas I. Paton, Andrew Nunn, Vincent M. Balanag, Padmasayee Papineni, Intan P Sari, Rovina Ruslami, Ka Lip Chew, Jitendra Kumar Saini, N. V. H ́ng, Celina Suresh, Qingshu Lu
article en
6 citations

Abstract

Singapore National Medical Research Council; UK Department of Health and Social Care; UK Foreign, Commonwealth, and Development Office; UK Medical Research Council; Wellcome Trust; and UK Research and Innovation Medical Research Council.

The Lancet Infectious DiseasesVol. 25(10)
Chulalongkorn University (TH), National University of Singapore (SG), Lung Center of the Philippines (PH), LRS Institute of Tuberculosis and Respiratory Diseases (IN), Infectious Diseases Institute (UG), HIV Netherlands Australia Thailand Research Collaboration (TH), RSUD Prof. Dr. Saiful Anwar Malang (ID), Tropical Disease Foundation (PH), National University Hospital (SG), Universitas Dr. Soetomo (ID), Universitas Islam Makassar (ID), University College London (GB), Makerere University (UG), Medical Research Council (GB), Padjadjaran University (ID)
Pfizer, Sanofi, Wellcome Trust, UK Research and Innovation, Department of Health and Social Care, National University Health System, Medical Research Council, National Medical Research Council
Good health and well-being
Openalex Percentile: Top 2%
Tuberculosis Research and Epidemiology
8.38
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.